Showing results (2071-2080 of 10,442) with videos related to

Sort By:
Pageof 1,045
AIDS (London, England)|December 21, 2022
HIV and race are independently associated with endothelial dysfunctionChristian Mouchati, Jared C Durieux, Sokratis N Zisis, et al.
AIDS (London, England)|December 21, 2022
Impact of pre-antiretroviral treatment HIV-RNA on time to successful virological suppression and subsequent virological failure - two nationwide, population-based cohort studiesErik Sörstedt, Malte Mose Tetens, Staffan Nilsson, et al.
AIDS (London, England)|December 21, 2022
Plasma osteopontin relates to myocardial fibrosis and steatosis and to immune activation among women with HIVJake A Robinson, Mabel Toribio, Thiago Quinaglia, et al.
AIDS (London, England)|December 6, 2022
Focused investigations to expedite cancer diagnosis among patients with lymphadenopathy in a tuberculosis and HIV-endemic regionKatherine Antel, Jenna Oosthuizen, Karryn Brown, et al.
AIDS (London, England)|December 13, 2022
Prevalence and risk factors of unsuppressed viral load among pregnant and breastfeeding women in sub-Saharan Africa: analysis from population-based surveysLeah A Schrubbe, Heidi Stöckl, Abigail M Hatcher, et al.
AIDS (London, England)|June 29, 2022
Evaluating the Determined, Resilient, Empowered, AIDS-free, Mentored, and Safe programme, what's worked and what more needs to be done?Saiqa Mullick, Frances M Cowan
AIDS (London, England)|June 29, 2022
The evolution of DREAMS: using data for continuous program improvementJanet Saul, Nora Toiv, Caroline Cooney, et al.
AIDS (London, England)|May 28, 2021
Assessing comorbidities and survival in HIV-infected and uninfected matched Medicare enrolleesXiaoying Yu, Jordan R Westra, Thomas P Giordano, et al.
AIDS (London, England)|May 28, 2021
Comparable HIV suppression by pegylated-IFN-α2a or pegylated-IFN-α2b during a 4-week analytical treatment interruptionEmmanouil Papasavvas, Livio Azzoni, Brian N Ross, et al.
AIDS (London, England)|July 5, 2021
Can HIV epidemics among MSM be eliminated through participation in preexposure prophylaxis rollouts?Sofía Jijón, Jean-Michel Molina, Dominique Costagliola, et al.
Pageof 1,045